Demand for cluster headache syndrome treatment will increase through 2036, with calcium channel blockers at a 27.0% share as the leading drug type segment. The market value stood at USD 1.0 billion in 2025 and is forecast to reach USD 1.9 billion by 2036 across key growth regions including India and China.